Long-term use of PCSK9i reduces CV events, including CV death - PACE-CME

Longterm use of PCSKi reduces CV events including CV death

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Women in cardiology research
Women in cardiology research
ESC 2022
Women in cardiology research
- Biljana Parapid, MD, PhD
Autoimmune diseases and risk of CVD
Autoimmune diseases and risk of CVD
ESC 2022
Autoimmune diseases and risk of CVD
- Prof. Naveed Sattar
Is class I recommendation for aspirin use in CVD prevention too strong?
Is class I recommendation for aspirin use in CVD prevention too strong?
ESC 2022
Is class I recommendation for aspirin use in CVD prevention too strong?
- Prof. John Cleland, MD
Understanding the effects of ARNI in acute MI
Understanding the effects of ARNI in acute MI
ESC 2022
Understanding the effects of ARNI in acute MI
- Otavio Berwanger, MD, PhD